非典型甲状旁腺肿瘤的全外显子组测序发现与甲状旁腺肿瘤发生相关的新基因和常见基因
对16例非典型甲状旁腺肿瘤(APT)进行全外显子组测序,共鉴定192个非同义变异,中位蛋白改变突变数为9。APT无特异性分子标签,但与甲状旁腺腺瘤和甲状旁腺癌共享基因组改变,PI3K/AKT/mTOR和Wnt信号通路为关键通路。
要点
- APT中常见突变基因包括BCOR、CLMN、EZH1、JAM2、KRTAP13-3、MUC16、MUC19和OR1S1。
- PI3K/AKT/mTOR和Wnt信号通路以及细胞外基质组织为失调通路。
- CDC73突变发生率低,其与复发风险的关系尚不明确。
核心结论
- APT似乎没有特异性分子特征,但与甲状旁腺腺瘤和甲状旁腺癌共享基因组改变。
- CDC73突变发生率低,这些突变是否与更高的复发风险相关仍不清楚。
- 本研究证实PI3K/AKT/mTOR和Wnt信号通路是甲状旁腺肿瘤发生的关键通路,并揭示了涉及染色质重塑、DNA和组蛋白甲基化的关键表观遗传修饰基因(BCOR、KDM2A、MBD4和EZH2)的突变。
研究设计与样本
- 对16例非典型甲状旁腺肿瘤(APT)进行全外显子组测序(WES)。
- 肿瘤DNA和匹配的外周血DNA使用Illumina HiSeq3000进行WES。
主要发现
- 共鉴定192个非同义变异,中位蛋白改变突变数为9。
- 最常突变的基因包括BCOR、CLMN、EZH1、JAM2、KRTAP13-3、MUC16、MUC19和OR1S1。
- 17个突变基因属于Cancer Gene Census列表。
- 通过STRING网络分析鉴定出的最一致枢纽基因为ATM、COL4A5、EZH2、MED12、MEN1、MTOR、PI3、PIK3CA、PIK3CB和UBR5。
- 失调通路包括PI3K/AKT/mTOR通路、Wnt信号和细胞外基质组织。
局限性
- CDC73突变发生率低,这些突变是否与更高的复发风险相关仍不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Atypical parathyroid tumor (APT) represents a neoplasm characterized by histological features typical of parathyroid carcinoma (PC) but lacking local infiltration and/or distant metastasis, leading to uncertainty regarding its malignant potential. OBJECTIVE: To characterize the molecular landscape and deregulated pathways in APT. METHODS: Whole-exome sequencing (WES) was conducted on 16 APTs. DNA from tumors and matched peripheral blood underwent WES using Illumina HiSeq3000. RESULTS: A total of 192 nonsynonymous variants were identified. The median number of protein-altering mutations was 9. The most frequently mutated genes included BCOR, CLMN, EZH1, JAM2, KRTAP13-3, MUC16, MUC19, and OR1S1. Seventeen mutated genes belong to the Cancer Gene Census list. The most consistent hub genes identified through STRING network analysis were ATM, COL4A5, EZH2, MED12, MEN1, MTOR, PI3, PIK3CA, PIK3CB, and UBR5. Deregulated pathways included the PI3 K/AKT/mTOR pathway, Wnt signaling, and extracellular matrix organization. Variants in genes such as MEN1, CDC73, EZH2, PIK3CA, and MTOR, previously reported as established or putative/candidate driver genes in benign adenoma (PA) and/or PC, were also identified in APT. CONCLUSION: APT does not appear to have a specific molecular signature but shares genomic alterations with both PA and PC. The incidence of CDC73 mutations is low, and it remains unclear whether these mutations are associated with a higher risk of recurrence. Our study confirms that PI3 K/AKT/mTOR and Wnt signaling represents the pivotal pathways in parathyroid tumorigenesis and also revealed mutations in key epigenetic modifier genes (BCOR, KDM2A, MBD4, and EZH2) involved in chromatin remodeling, DNA, and histone methylation.
引用
- Pardi E, Poma AM, Torregrossa L, et al. Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis. J Clin Endocrinol Metab. 2024. PMID: 38940486. doi:10.1210/clinem/dgae441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。